INTRODUCTION
============

Genes in eukaryotic cells contain introns, which are transcribed into precursor mRNA (pre-mRNA) and later removed by the RNA-splicing machinery, the spliceosomes ([@B83]; [@B75]). The spliceosomal complexes contain both RNA and proteins. Specifically, five uridine-rich small nuclear RNAs (snRNAs), U1, U2, U4, U5, and U6, together with various proteins, assemble into large ribonucleoprotein (snRNP) complexes that function at various stages of splicing ([@B83]; [@B75]). Among the many proteins associated with snRNPs, Prp40 (pre-mRNA-processing protein 40) was initially identified in the budding yeast *Saccharomyces cerevisiae* as a splicing factor and is essential for cell viability ([@B39]). Prp40 has been implicated in the early stages of spliceosome assembly when it associates with the U1 snRNP and is involved in the recognition of the 5′ splicing site ([@B7]). In mammalian cells, there are two homologues of Prp40, PRPF40A and PRPF40B: PRPF40A is also known as HYPA (Huntingtin-interacting protein A) or FBP11 (formin-binding protein 11), and PRPF40B is also known as HYPC (Huntingtin-interacting protein C) or FBP21 (formin-binding protein 21) ([@B16]; [@B10]; [@B26]; [@B37]). In general, these Prp40 homologues play roles in splicing but may also play nonsplicing-related roles ([@B20]; [@B51]). Prp40 and its mammalian homologues all contain two tyrosine-rich WW domains at the N-terminus followed by several FF (phenylalanine-phenylalanine) domains ([@B9]). A WW domain normally contains 35 to 40 amino acids (aa) and binds to motifs with core proline-rich sequences, and a FF domain is an unusual phosphopeptide-binding module with about 60 aa and often follows a WW domain in the same protein ([@B9]; [@B4]; [@B38]). The WW domains in human PRPF40A and PRPF40B interact with proteins such as huntingtin involved in Huntington's disease and MeCP2 involved in Rett syndrome ([@B26]; [@B63]; [@B14]). Although Prp40 in *S. cerevisiae* has been studied in detail, its homologues in other systems have not been well studied.

We have been using the filamentous fungus *Aspergillus nidulans* as a genetic model organism for studying the function of cytoplasmic dynein, a minus-end-directed microtubule motor that transports various cargoes in eukaryotic cells ([@B69]; [@B58]). Cytoplasmic dynein is a multi-component complex with the two heavy chains (HCs) containing motor domains for ATP-dependent motility along microtubules ([@B11]; [@B73]; [@B31]), and its function requires dynactin, another multi-component complex important for dynein--cargo interaction and dynein activation ([@B74]; [@B69]; [@B58]). In *A. nidulans* and other filamentous fungi, dynein is responsible for distributing multiple nuclei along hyphae and for transporting a variety of cargoes including early endosomes and cargoes that hitchhike on early endosomes ([@B84]; [@B6]; [@B25]; [@B92], [@B88]; [@B64]; [@B70]; [@B77]). To identify proteins that are required for dynein-mediated early-endosome transport, we took a genetic approach to screen for mutants defective in *[e]{.ul}*arly-*[e]{.ul}*ndosome *[d]{.ul}*istribution (*eed*) ([@B98], [@B97]; [@B107]). From the *eed* mutants, we have identified genes encoding for the HookA, FhipA, and VezA proteins ([@B98], [@B97]; [@B107]). HookA and FhipA are components of the Fts-Hook-Fhip (FHF) complex that link early endosomes to dynein--dynactin ([@B95]; [@B12]; [@B98]; [@B107]; [@B32]; [@B69]; [@B58]), and VezA is homologous to human vezatin whose higher eukaryotic homologues have just been found to participate in dynein functions ([@B76]).

Here we report the study of a new *eed* mutant, *eedD*5, which exhibited an obvious defect in dynein-mediated transport of early endosomes as well as a mild defect in nuclear distribution. We identified the *eedD* gene as the Prp40 homologue in *A. nidulans* (Prp40A), and the *eedD*5 mutation is the nonsense Prp40A^L438\*^ mutation.

RESULTS
=======

The *eedD5* mutation is identified as *prp40A* ^L438\*^
-------------------------------------------------------

The *eedD*5 mutant was isolated after UV mutagenesis of a strain containing mCherry-labeled RabA and GFP-labeled Histone-H1, which allowed observation of early endosomes and nuclei, respectively ([@B2]; [@B94]; [@B110]; [@B1]; [@B24]). The *eedD*5 mutant formed a colony obviously smaller than that of a wild type ([Figure 1A](#F1){ref-type="fig"}). In *A. nidulans*, the plus ends of microtubules face the hyphal tip and minus ends are either at the spindle-pole body or at the septum ([@B57]; [@B34]; [@B44]; [@B23]; [@B94]; [@B24]; [@B101]; [@B103]; [@B27]). An abnormal accumulation of early endosomes at the hyphal tip was obvious in every single hypha of the mutant ([Figure 1B](#F1){ref-type="fig"}), indicating a defect in dynein-mediated early-endosome transport ([@B46]; [@B2]; [@B100]; [@B110], [@B109]; [@B24]). Nuclear distribution was mildly affected as about half of the spore heads in the mutant contained two nuclei instead of a single nucleus in a vast majority of wild-type hyphae ([Figure 1C](#F1){ref-type="fig"}), whereas a nuclear-distribution (*nud*) mutant in the dynein pathway typically shows four or more nuclei inside the spore head ([@B62]; [@B89], [@B91]).

![Phenotype of the *eedD*5 mutant. (A) Colony phenotypes of the *eedD*5 mutant and a wild-type strain. (B) Microscopic images showing the distributions of mCherry--RabA-labeled early endosomes (mCherry-RabA) in wild type and the *eedD*5 mutant. Bar, 5 μm. Although bidirectional movements of mCherry--RabA-labeled early endosomes are not completely abolished, most of the *eedD*5 hyphal tips (∼80%) show an abnormal accumulation of mCherry-RabA signals (*n* = 50). Hyphal tip is indicated by a yellow arrow. (C) Images of nuclei labeled with GFP-tagged Histone H1 in wild type and the *eedD*5 mutant. Spore head is indicated by a yellow arrowhead.](mbc-31-1289-g001){#F1}

To determine whether the defect in early-endosome transport and the small-colony phenotype are genetically linked or caused by the same mutation, we crossed the *eedD*5 mutant with a wild-type strain. We found that five progeny with the small-colony phenotype all showed the abnormal accumulation of early endosomes at the hyphal tip, while five progeny with normal colony size all showed normal distribution of early endosomes. This result indicated that the colony phenotype and the early-endosome-distribution phenotype are causally linked to the same locus. To identify the *eedD*5 mutation, we combined the spores from the five mutant strains and prepared genomic DNA from the mutant sample for whole genome sequencing. As a control, we also prepared genomic DNA from five wild-type strains, and whole genome sequencing of the wild-type sample was performed together with the mutant sample. Whole-genome sequencing was done using the genome sequencing and bioinformatic service of Otogenetics ([www.otogenetics.com](http://www.otogenetics.com)). We used the software Integrative Genomics Viewer (IGV 2.4.3) to visualize the genomic sequencing data to identify the mutation. The *eedD*5 mutation was found in An1249 ([www.AspGD.org](http://www.AspGD.org)), which encodes a protein with 798 aa, and the mutation substituted a T with A that changed the codon for leucine (TTA) to a stop codon (TAA) at residue 438. The protein encoded by An1249 is homologous to the budding yeast Prp40 (Supplemental Figure S1), a previously studied mRNA splicing factor associated with U1 snRNP ([@B7]). We named this protein Prp40A (Prp40 in *A. nidulans*). Prp40A (798 aa) is much bigger than Prp40 (583 aa). Similar to the yeast Prp40, which contains two WW domains followed by four FF domains (SMART domain analysis), Prp40A contains two WW domains followed by five FF domains ([Figure 2A](#F2){ref-type="fig"}). The *eedD5* mutation (the only *eedD* mutant allele so far), identified as *prp40A*^L438\*^, should result in a C-terminal truncated protein missing the last FF domain.

![Phenotypic analysis of the strain containing the Prp40A(1-437)-GFP fusion gene. (A) Domain structures of Prp40 proteins in different organisms including PRPF40A (human), PRPF40B (human), Prp40 (budding yeast), and Prp40A (*A. nidulans*). Position of the *eedD*5 mutation, *prp40A*^L438\*^, is indicated by a black arrow. (B) Colony phenotypes of the strains containing different Prp40A alleles. (C) Localization of Prp40A-GFP or Prp40A(1-437)-GFP and mCherry--RabA-labeled early endosomes in strains containing one of the GFP fusions. Hyphal tip is indicated by a yellow arrow. Bar, 5 μm. (D) A quantitative analysis on the ratio of GFP signal intensity in the cytoplasm to that in the nucleus (Prp40A-GFP: *n* = 30; Prp40A(1-437)-GFP: *n* = 30). Scatter plots with mean and SD values were generated by Prism 8. The Mann--Whitney test (unpaired, two-tailed) was used for analyzing the two data sets without assuming normal distribution of the data. \*\*\*\**p* \< 0.0001. (E) A Western blot detecting the Prp40A(1-437)-GFP fusion, suggesting that the fusion protein is stable. The polyclonal anti-GFP antibody (Clontech) was used to probe the blot.](mbc-31-1289-g002){#F2}

The Prp40A(1-437)-GFP fusion is defective in localization and function
----------------------------------------------------------------------

To characterize the putative truncated Prp40A in the *eedD*5 mutant, we constructed a strain containing the Prp40A(1-437)-GFP fusion gene at the *prp40A* locus, and we also constructed a strain containing the full-length (FL) Prp40A-GFP at the *prp40A* locus as a control. While the strain containing the FL Prp40A-GFP formed a normal colony, the strain containing the Prp40A(1-437)-GFP fusion formed a small colony just like that formed by the *prp40A*^L438\*^ mutant ([Figure 2B](#F2){ref-type="fig"}). In the strain containing the FL Prp40A-GFP, GFP signals labeled the nuclei, and mCherry--RabA-labeled early endosomes distributed normally along hyphae ([Figure 2C](#F2){ref-type="fig"}). However, in the strain containing Prp40A(1-437)-GFP, the GFP signals appeared in both nuclei and cytoplasm, and mCherry--RabA-labeled early endosomes abnormally accumulated at the hyphal tip ([Figure 2C](#F2){ref-type="fig"}). These data not only confirmed the *eedD*5 causal mutation being Prp40A^L438\*^ but also showed that the C-terminus of Prp40A is important but not essential for the nuclear localization of Prp40A, a point further supported by our quantitative analysis of the nuclear and cytoplasmic intensity of GFP signals ([Figure 2D](#F2){ref-type="fig"}). The C-terminal truncated Prp40A(1-437)-GFP protein of expected size was clearly detected on a Western blot probed with an anti-GFP antibody, suggesting that the truncated protein is stably expressed but functionally defective ([Figure 2E](#F2){ref-type="fig"}).

The Prp40A(1-437)-GFP and Prp40A-GFP fusion proteins associate with RNA-splicing factors and proteins involved in actin- and/or microtubule-based functions
-----------------------------------------------------------------------------------------------------------------------------------------------------------

To verify that Prp40A is associated with the splicing machinery in *A. nidulans*, we used a Prp40A-GFP-containing strain for a proteomic analysis on proteins pulled down with Prp40A-GFP. In the same experiment, we also included the Prp40A(1-437)-GFP-containing strain for comparison. Our proteomic analysis indicates that the FL Prp40A-GFP is associated with many splicing factors, including the top hit Prp8, the largest spliceosomal protein, and proteins in the Prp19 complex ([Table 1](#T1){ref-type="table"}). Many of these proteins were also pulled down with the truncated (TR) Prp40A(1-437)-GFP ([Table 1](#T1){ref-type="table"}). While some splicing factors appear to associate preferentially with the FL Prp40A-GFP, others seem to associate preferentially with the truncated Prp40A(1-437)-GFP ([Table 1](#T1){ref-type="table"}). The result that the truncated protein still associates with many splicing factors suggests that its splicing function may at least be partially retained.

###### 

Some pre-mRNA splicing proteins pulled down with the FL Prp40A-GFP (FL) and the truncated Prp40A(1-437)-GFP (TR).

                           FL (total)   TR (total)   FL (unique)   TR (unique)   FL (coverage)   TR (coverage)
  ------------------------ ------------ ------------ ------------- ------------- --------------- ---------------
  Prp8 (An4523, 2940aa)    270          142          72            54            25.40%          21.30%
  Brr2 (An10194, 2208aa)   264          127          67            59            31.90%          28.80%
  Prp19 (An6906, 475aa)    42           4            5             3             17.10%          11.80%
  Syf1 (An0111, 867aa)     38           20           17            12            22.60%          17.40%
  Cus1 (An5098, 549aa)     37           24           14            13            37.20%          34.20%
  Clf1 (An1259, 673aa)     32           11           14            9             23.80%          18.10%
  Prp21 (An4760, 530aa)    29           8            10            5             24.40%          17.60%
  Msl5 (An10615, 554aa)    27           14           6             6             18.40%          15.00%
  Prp9 (An8015, 502aa)     25           8            11            6             23.10%          15.10%
  Prp4 (An1468, 520aa)     19           4            8             3             20.50%          7.70%
  Prp17 (An5196, 531aa)    18           2            7             2             18.60%          3.40%
  Prp39 (An1635, 588aa)    17           3            9             3             16.50%          5.60%
  Prp45 (An8180, 583aa)    17           8            8             5             19.20%          13.20%
  Prp3 (An0727, 520aa)     15           6            6             6             16.20%          16.80%
  Prp31 (An1260, 521aa)    14           5            7             4             21.90%          12.70%
  Snp1 (An6903, 373aa)     13           6            6             5             19.80%          18.20%
  Cwc22 (An0289, 760aa)    13           4            6             3             7.60%           4.30%
  Smb1 (An10561, 196aa)    12           4            5             2             27.60%          11.70%
  Prp46 (An1208, 452aa)    12           2            6             2             21.00%          4.90%
  Smd2 (An1802, 114aa)     10           5            4             2             43.40%          17.70%
  Syf2 (An1861, 297aa)     9            0            4             0             19.90%          0%
  Slt11 (An7145, 377aa)    8            0            5             0             20.40%          0%
  Slu7 (An4788, 466aa)     8            0            6             0             16.70%          0%
  Cwf7 (An4244, 215aa)     7            0            4             0             21.90%          0%
  Usp107 (An6036, 762aa)   95           327          24            40            28.50%          42.40%
  Prp10 (An2420, 1241aa)   13           85           9             31            9.90%           31.40%
  Cwf10 (An1408, 985aa)    23           52           13            20            14.80%          26.80%
  Prp6 (An7447, 941aa)     12           41           7             21            11.20%          26.00%
  Cwf11 (An7014, 1422aa)   2            24           2             15            1.90%           15.50%
  Prp5 (An1266, 1173aa)    2            23           2             17            3.00%           21.10%
  Prp28 (An1634, 782aa)    9            23           4             10            7.90%           19.20%
  Luc7 (An1776, 279aa)     13           20           5             7             20.10%          22.80%
  Prp22 (An4721, 1241aa)   0            6            0             5             0%              7.00%

Proteins preferentially pulled down with FL are listed in the top part, and those preferentially pulled down with TR are listed in the bottom part. *S. cerevisiae* names are used unless there is no *S. cerevisiae* homologue or if the name of the *S. pombe* homologue indicates more clearly a role in RNA splicing than that of the *S. cerevisiae* homologue.

Interestingly, some proteins required for the actin cytoskeleton function and/or endocytosis were preferentially pulled down with the truncated protein Prp40A(1-437)-GFP ([Table 2](#T2){ref-type="table"}) ([@B29]). The top hit is SepA, the only formin protein in *A. nidulans* ([@B35]; [@B13]). This was not entirely unexpected given that the Prp40 homologues FBP11 and FBP21 were identified as FBPs because their WW domains bind to formin's proline-rich motifs ([@B16]; [@B10]). Homologues of Pan1 and Las17/WASP ([@B29]), both containing proline-rich motifs, were also pulled down ([Table 2](#T2){ref-type="table"}). Other proteins involved in the actin cytoskeleton and endocytosis were pulled down presumably because they are associated with these proteins ([@B29]).

###### 

Some proteins involved in functions of the actin cytoskeleton and/or endocytosis pulled down with the truncated Prp40A(1-437)-GFP (TR) or the FL Prp40A-GFP (FL).

                                            TR (total)   FL (total)   TR (unique)   FL (unique)   TR (coverage)   FL (coverage)
  ----------------------------------------- ------------ ------------ ------------- ------------- --------------- ---------------
  \*SepA formin (An6523,1762aa)             225          23           69            14            39.70%          11.30%
  SlaB (An2756, 1022aa)                     85           0            34            0             44.70%          0%
  \*Pan1 homologue (An4270, 1484aa))        76           0            30            0             28.20%          0%
  Clathrin HC (An4463, 1676aa)              67           0            36            0             25.80%          0%
  Myosin V (An8862, 1569aa)                 51           0            28            0             25.00%          0%
  RGD2 homologue (An5677, 883aa)            21           0            11            0             14.50%          0%
  AmpA Amphiphysin (An2516, 413aa)          10           0            7             0             27.90%          0%
  \*Las17/WASP homologue (An11104, 657aa)   8            0            5             0             9.40%           0%
  Sla1 homologue (An1462, 1113aa)           7            0            6             0             11.60%          0%
  AmpB Amphiphysin (An8831, 261aa)          6            0            4             0             24.10%          0%
  Myosin I or MyoA (An1558, 1249aa)         5            0            3             0             3.80%           0%
  Ent2 homologue (An3696, 561aa)            5            0            2             0             8.60%           0%

\*Containing proline-rich motifs that could possibly bind the WW domains of Prp40A directly.

Importantly, several proteins involved in dynein- and microtubule-based functions were also pulled down, including the dynein HC, the LC8 dynein light chain, Arp1 of dynactin, and p50 of dynactin ([Table 3](#T3){ref-type="table"}) ([@B43]; [@B74]; [@B18]; [@B81]).

###### 

Proteins involved in dynein- or microtubule-based functions pulled down with the FL Prp40A-GFP and the truncated Prp40A(1-437)-GFP (TR).

                                               FL (total)   TR (total)   FL (unique)   TR (unique)   FL (coverage)   TR (coverage)
  -------------------------------------------- ------------ ------------ ------------- ------------- --------------- ---------------
  NudA/dynein HC (An0118, 4345aa)              6            7            6             6             2.00%           2.00%
  p50 of dynactin (An3589, 467aa)              6            3            5             3             11.60%          6.40%
  NudK/Arp1 of dynactin (An1953, 380aa)        2            5            1             1             3.90%           3.90%
  NudG/LC8 dynein light chain (An0420, 94aa)   1            0            1             0             23.40%          0%
  NudF/LIS1 (An6197, 444aa)                    1            0            1             0             3.20%           0%
  NudM/p150 of dynactin (An6323, 1342aa)       0            1            0             1             0%              1.30%
  ClipA/CLIP-170 (An1475, 672aa)               1            0            1             0             2.20%           0%
  KinA/kinesin-1 (An5343, 927aa)               0            1            0             1             0%              1.40%
  KipB/Kip3/kinesin-8 (An3970, 464aa)          1            8            1             5             2.70%           11.80%
  UncA/kinesin-3 (An7547, 1630aa)              1            0            1             0             0.90%           0%
  BenA beta tubulin (An1182, 447aa)            16           22           7             7             20.40%          20.40%
  TubB alpha tubulin (An7570, 451aa)           2            10           1             7             2.40%           22.00%
  MipA gamma tubulin (An0676, 454aa)           1            0            1             0             3.30%           0%
  TubC beta tubulin (An6838, 449aa)            0            4            0             3             0%              10.00%

The ∆ *prp40A* mutant exhibits a partial defect in dynein-mediated processes
----------------------------------------------------------------------------

To determine if the phenotype of the original *prp40A* truncation mutant *prp40A*^L438\*^ is caused by a loss-of-function of the protein or a gain-of-function of the truncated protein Prp40A(1-437), we constructed the deletion mutant of *prp40A*, ∆*prp40A*, in which the whole open reading frame of Prp40A is deleted. The ∆*prp40A* mutant exhibited a much more severe growth defect than that exhibited by the *prp40A*^L438\*^ mutant, but it still formed a tiny colony ([Figure 3A](#F3){ref-type="fig"}). Thus, Prp40A is not an essential protein in *A. nidulans*. To determine if RNA splicing in general is essential for *A. nidulans* growth, we created deletion constructs for genes encoding Prp5 ([@B3]) and Clf1 ([@B19]; [@B28]) homologues in *A. nidulans* (*prp5A* and *clf1A*) (Supplemental Figures S2 and S3). Neither the *prp5A*-null mutant nor the *clf1A*-null mutant in *A. nidulans* is viable as shown by heterokaryon analyses (Supplemental Figure S4) ([@B61]). Specifically, transformants that grew on nonselective medium were not able to grow on the medium selective for the *AfpyrG* marker linked to the deletion constructs (Supplemental Figure S4) ([@B61]). Together, these results suggest that while splicing in general is essential for the viability of *A. nidulans* strains, Prp40A is not essential, which differs from the situation in budding yeast where Prp40 is essential for viability ([@B39]).

![Phenotype of the ∆*prp40A* mutant. (A) Colony phenotypes of a wild-type strain, the *prp40A*^L438\*^ mutant and the ∆*prp40A* mutant. (B) Microscopic images showing the distributions of mCherry--RabA-labeled early endosomes (mCherry-RabA) in wild type and the ∆*prp40A* mutant. Hyphal tip is indicated by a yellow arrow. Bar, 5 μm. (C) Images of nuclei labeled with GFP-tagged Histone H1 in wild type and the ∆*prp40A* mutant. Spore head is indicated by a yellow arrowhead. (D) A quantitative analysis on the percentage of germ tubes containing 0, 1, 2, or 3 nuclei in the spore head (wild type: *n* = 59; *prp40A*^L438\*^: *n* = 43; ∆*prp40A*: *n* = 57). The number of nuclei in the spore head of the *prp40A*^L438\*^ mutant or the ∆*prp40A* mutant is higher than that in wild type (*p* \< 0.0001 in both cases, Kruskal--Wallis ANOVA test with Dunn's multiple comparisons test, unpaired). However, the number of nuclei in the spore head of the *prp40A*^L438\*^ mutant is not significantly different from that in the ∆*prp40A* mutant (*p* \> 0.05, Kruskal--Wallis ANOVA test with Dunn's multiple comparisons test, unpaired).](mbc-31-1289-g003){#F3}

Importantly, the ∆*prp40A* mutant exhibited an abnormal accumulation of early endosomes (mCherry-RabA) at the hyphal tip ([Figure 3B](#F3){ref-type="fig"}), similar to that exhibited by the *prp40A*^L438\*^ mutant. In addition, the ∆*prp40A* mutant exhibited a mild defect in nuclear distribution. In the ∆*prp40A* mutant, about half of the germ tubes have two nuclei inside the spore head, just like that in the *prp40A*^L438\*^ mutant but unlike wild-type germ tubes, which usually have one nucleus in the spore head ([Figure 3, C and D](#F3){ref-type="fig"}). Thus, the *prp40A*^L438\*^ and ∆*prp40A* mutants exhibited similar defects in dynein-mediated processes, suggesting that the *prp40A*^L438\*^ mutation is a loss-of-function rather than a gain-of-function mutation. In addition, combined with the fact that the *prp40A*^L438\*^ mutant grows much better than the ∆*prp40A* mutant, this result also suggests that *prp40A*^L438\*^ represents a function-separating mutation that partially separates Prp40A's splicing and dynein-related functions. Because the *prp40A*^L438\*^ mutant grows much better than the ∆*prp40A* mutant ([Figure 3A](#F3){ref-type="fig"}), we used only the *prp40A*^L438\*^ mutant for further analyses.

The *prp40A* ^L438\*^ mutation decreases the amount of Arp1 associated with Arp11
---------------------------------------------------------------------------------

The in vivo function of dynein requires dynactin, a complex containing multiple components including p150 and the actin-related protein Arp1, which forms a mini-filament whose pointed end binds directly to another actin-related protein Arp11 ([@B22]; [@B74]; [@B18]; [@B81]; [@B69]; [@B58]). In *A. nidulans*, the Arp11 protein is encoded by a gene (An3185) ([@B108]) without any intron. From a previous study on mammalian dynactin, we also know that Arp11 can stably exist within the pointed-end subcomplex without Arp1 ([@B22]). Thus, we made an Arp11-GFP strain and used it for protein pull-down experiments. As shown by Western analyses, the amount of Arp1 pulled down with Arp11-GFP is lowered in the *prp40A*^L438\*^ mutant ([Figure 4, A and B](#F4){ref-type="fig"}). This could be related to splicing as Arp1 is encoded by a gene (An1953, *nudK*) ([@B93]) with two introns, but this could also be related to a moonlighting function of Prp40A on dynactin assembly.

![Decreased amounts of Arp1 pulled down with Arp11-GFP and decreased microtubule plus-end accumulation of dynein--dynactin in the *prp40A*^L438\*^ mutant. (A) Western blots showing that the amount of Arp1 pulled down with Arp11-GFP is lower in the *prp40A*^L438\*^ mutant than in the wild-type control. (B) A quantitative analysis on the ratio of pulled-down Arp1 to Arp11-GFP (Arp1/Arp11-GFP). The values were generated from Western analyses of four independent pull-down experiments (*n* = 4 for all). The wild-type values are set as 1. Scatter plots with mean and SD values were generated by Prism 8. \*\*\**p* \< 0.001 (Student's *t* test, two-tailed, unpaired, normal distribution was assumed). (C) Images of GFP-dynein in wild type and the *prp40A*^L438\*^ mutant. Hyphal tip is indicated by a light brown arrow. Bar, 5 μm. (D) Images of dynactin p150-GFP in wild type and the *prp40A*^L438\*^ mutant. Hyphal tip is indicated by a light brown arrow. (E) A quantitative analysis on GFP-dynein comet intensity in wild type (*n* = 42) and the *prp40A*^L438\*^ mutant (*n* = 35). (F) A quantitative analysis on p150-GFP comet intensity in wild type (*n* = 36) and the *prp40A*^L438\*^ mutant (*n* = 41). For both E and F, all values are relative to the average value for wild type, which is set as 1. Scatter plots with mean and SD values were generated by Prism 8. The Mann--Whitney test (unpaired, two-tailed) was used for analyzing the two data sets without assuming normal distribution of the data. \*\*\*\**p* \< 0.0001.](mbc-31-1289-g004){#F4}

The *prp40A* ^L438\*^ mutation decreases the microtubule plus-end accumulation of dynein--dynactin
--------------------------------------------------------------------------------------------------

In fungi and higher eukaryotic cells, GFP-labeled dynein and dynactin accumulate at the dynamic microtubule plus ends, which were represented by the dynamic comet-like structures ([@B87]). In filamentous fungi, dynein and dynactin form plus-end comets near the hyphal tip ([@B34]; [@B105]), which is important for dynein-mediated early-endosome transport ([@B46]). To test if the plus-end accumulation of dynein or dynactin is defective in the *prp40A*^L438\*^ mutant, we examined GFP-dynein HC and p150-dynactin-GFP signals in the *prp40A*^L438\*^ background. We found that the comet signal intensity of either GFP-dynein HC or p150-dynactin-GFP was significantly reduced in the mutant ([Figure 4, C--F](#F4){ref-type="fig"}). This is consistent with Arp1 being affected by the mutation, because Arp1 is important for the stability of dynactin p150 ([@B54]; [@B33]; [@B108]), both Arp1 and p150 are required for dynein--dynactin interaction ([@B40]; [@B82]; [@B18]; [@B81], [@B80]; [@B30]), and both are required for the plus-end localization of *A. nidulans* dynein ([@B90]; [@B34]; [@B105], [@B108]; [@B24]; [@B99]). However, it is hard to totally exclude the possibility that this reduction in the plus-end accumulation of dynein is due to a general decrease in the amounts of dynein--dynactin components, as most of them are encoded by intron-containing genes. For example, the genes encoding dynein intermediate chain (NudI, An1454), dynein light intermediate chain (NudN, An4664), and the 8-kD dynein light chain (NudG, An0420) all contain two or more introns and all of these proteins are important for the plus-end accumulation of dynein in *A. nidulans* ([@B8]; [@B104], [@B106]; [@B50]).

The *prp40A* ^L438\*^ mutation decreases the frequency but not the speed of dynein-mediated early-endosome transport
--------------------------------------------------------------------------------------------------------------------

To examine in more detail how the defects detected in the *prp40A*^L438\*^ mutant affect dynein-mediated early-endosome transport, we measured the frequency and speed of early-endosome transport away from the hyphal tip in wild type and the *prp40A*^L438\*^ mutant ([Figure 5, A--C](#F5){ref-type="fig"}). While the frequency of dynein-mediated transport is significantly decreased in the mutant, the speed is not significantly affected ([Figure 5, A--C](#F5){ref-type="fig"}).

![A quantitative analysis on dynein-mediated early-endosome transport in the *prp40A*^L438\*^ mutant showing a decrease in the frequency but not the speed of the transport. (A) Kymographs showing the movements of early endosomes in wild type and the *prp40A*^L438\*^ mutant. Green arrows indicate dynein-mediated movements away from the hyphal tip. (B) A quantitative analysis on the frequency of dynein-mediated transport in wild type (*n* = 37 hyphal tips) and the *prp40A*^L438\*^ mutant (*n* = 39 hyphal tips). Scatter plots with mean and SD values were generated by Prism 8. \*\*\*\**p* \< 0.0001 (unpaired, Mann--Whitney test, Prism 8). (C) A quantitative analysis on the speed of dynein-mediated early-endosome movement in wild type (*n* = 88 movements) and the *prp40A*^L438\*^ mutant (*n* = 44 movements). The difference between wild type and the mutant is insignificant at *p* = 0.05 (unpaired, Mann--Whitney test, Prism 8).](mbc-31-1289-g005){#F5}

DISCUSSION
==========

Via a screen for mutants defective in dynein-mediated early-endosome transport, we identified the *prp40A*^L438\*^ mutation that causes a C-terminal truncation of Prp40A, the *A. nidulans* homologue of Prp40, which is an essential splicing factor in budding yeast. In *A. nidulans*, many genes essential for colony growth contain introns. For example, a never-in-mitosis gene *nimA* (An9504) contains two introns, and NimA is essential for colony formation ([@B55]; [@B59], [@B60]). The fact that the ∆*prp40A* mutant still formed a tiny colony indicates that Prp40A is not essential for splicing. Interestingly, the *prp40A*^L438\*^ mutant formed a colony that is much healthier than that of the ∆*prp40A* mutant, suggesting that the splicing function of Prp40A may only be partially lost in the *prp40A*^L438\*^ mutant. Given this and the result that the *prp40A*^L438\*^ and ∆*prp40A* mutations cause similar defects in dynein-mediated processes, we postulate that Prp40A may have a moonlighting function that affects dynein-mediated processes.

It has been reported that another splicing factor has microtubule-related function in the filamentous fungus *Ustilago maydis*, where the Num1 protein in the Prp19 complex interacts with kinesin-1, thereby affecting dynein localization and function ([@B42]; [@B111]). Kinesin-1 is indeed important for the plus-end accumulation of dynein in filamentous fungi and neurons (note that in higher eukaryotes, kinesin light chains interact with dynein intermediate chains directly) ([@B105]; [@B47]; [@B46]; [@B5]; [@B79]), and it is important for dynein-mediated early-endosome transport ([@B46]). In the *A. nidulans* kinesin-1 mutant, both dynein and dynactin decorate along microtubules ([@B110]; [@B99]). However, this was not seen in the *prp40A*^L438\*^ mutant. The *A. nidulans* homologue (An4244) of *U. maydis* Num1 (fission yeast Cwf7) is associated with Prp40A-GFP ([Table 1](#T1){ref-type="table"}). However, the number of total peptide from kinesin-1 (a 927-aa protein) detected in the Prp40A(1-437)-GFP pull down is only one whereas the total peptide number was five for Arp1 (a much smaller 380-aa protein) ([Table 3](#T3){ref-type="table"}), suggesting that Arp1 is more likely a true interactor than kinesin-1. It is also interesting to note that the mammalian Prp40 homologues interact with Huntingtin ([@B26]; [@B63]), a protein interact with dynein--dynactin and affects dynein function ([@B15]; [@B48]; [@B86]). However, no Huntingtin homologue is found in *A. nidulans* genome.

In the *prp40A*^L438\*^ mutant, the amount of Arp1 pulled down with Arp11-GFP was decreased. This could be splicing-related, but we would not exclude the possibility that Prp40A affects Arp1 stability or Arp1 mini-filament assembly in a splicing-independent manner. Notably, we recently found that a mammalian Prp40 homologue PRPF40A was identified as one of the 32 total proteins interacting with Arp1 (ACTR1B) (<https://thebiogrid.org/230579/summary/mus-musculus/actr1b.html>) ([Table 4](#T4){ref-type="table"}) ([@B36]). Moreover, PRPF40A was also identified as one of the 74 total proteins interacting with p24 (DCTN3) (<https://thebiogrid.org/207318/summary/mus-musculus/dctn3.html?sort=evidence>) that is located on the Arp1 mini-filament with p50 ([@B21]; [@B41]; [@B65]; [@B22]; [@B74]; [@B53]; [@B17]; [@B36]; [@B81]). Among the 32 Arp1 interactors, many are components of the dynactin complex and chaperonins that could be involved in the assembly of the complex ([Table 4](#T4){ref-type="table"}) ([@B36]). Importantly, both PRPF40A and vezatin are among the interactors ([Table 4](#T4){ref-type="table"}). The *A. nidulans* vezatin homologue VezA was identified from a mutant screen similar to the one performed in this study ([@B97]). Although mammalian vezatin was initially identified as a protein involved in cell adhesion ([@B45]), vezatin homologues in Drosophila and zebrafish have recently been found to play roles in dynein-mediated axonal transport ([@B76]). Thus, our genetic approach has continued to identify conserved dynein regulators. Our current data combined with the mammalian interactome data suggest the possibility that Prp40 homologues may affect Arp1 either directly or indirectly, which may promote either the stability of Arp1 or its function. The Arp1 mini-filament is the backbone of the dynactin complex ([@B71]; [@B18]; [@B81]), and this filament provides the binding sites for not only the dynein tails but also the coiled-coiled domains of several dynein-activating cargo adapters ([@B18]; [@B81], [@B80]; [@B30]; [@B69]; [@B58]). In the *prp40A*^L438\*^ mutant, there is an obvious decrease in the frequency but not the speed of dynein-mediated early-endosome transport. This could be resulted from a decrease in the number of functional dynein--dynactin molecules at the plus end to support the dynein--dynactin--cargo interaction, but it is also possible that some dynein--dynactin--cargo complexes assembled at the plus end may be too abnormal to support cargo-activated initiation of dynein movement ([@B46]; [@B52]; [@B72]; [@B102]; [@B68]). While Prp40A's mechanism of action needs to be further studied, we report our genetic finding and suggest that it may be worthwhile to examine the possible roles of Prp40 homologues in dynein functions in higher eukaryotes.

###### 

A list of the 32 unique interactors of ACTR1B (Arp1 actin-related protein 1B).

  Gene          Protein
  ------------- ------------------------------------------------------------------------------------
  MTNR1A        melatonin receptor 1A
  SNCA          synuclein, alpha (non A4 component of amyloid precursor
  CCT8          chaperonin-containing TCP1, subunit 8 (theta)
  ATXN1         ataxin-1
  SYNPO2        synaptopodin 2
  DCTN5         dynactin-5 (p25)
  OBSCN         obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
  PDCL3         phosducin-like 3
  ACTR10        dynactin Arp11 or actin-related protein 10 homologue (S. cerevisiae)
  POLR3B        RNA polymerase III polypeptide B
  **PRPF40A**   **PRP40 pre-mRNA processing factor 40 homologue A (S. cerevisiae)**
  VEZT          Vezatin, adherens junctions transmembrane protein
  DCTN4         dynactin 4 (p62)
  CCT5          Chaperonin-containing TCP1, subunit 5 (epsilon)
  DCTN3         dynactin-3 (p22 or p24)
  DCTN6         dynactin 6 (p27)
  KCNMA1        Potassium large conductance calcium activated channel, subfamily M, alpha member 1
  CCT2          chaperonin-containing TCP1, subunit 2 (beta)
  CCT4          chaperonin-containing TCP1, subunit 4 (delta)
  DCTN2         dynactin 2 (p50)
  ACTR1A        Arp1 actin related protein 1 homologue A, centractin alpha
  MTA1          metastasis associated 1
  YWHAH         Tyrosine 3-monoxygenase/tryptophan 5-monoxygenase activation protein
  CCT3          chaperonin-containing TCP1, subunit 3 (gamma)
  TCP1          t-complex 1, CCT-alpha
  SVIL          Supervillain
  DCTN1         dynactin 1 (p150)
  CCT6A         chaperonin-containing TCP1, subunit 6A (zeta 1)
  CAPZB         capping protein (actin filament), beta
  CAPZA2        capping protein (actin filament), alpha 2
  CAPZA1        capping protein (actin filament), alpha 1
  MAPT          Microtubule-associated protein tau

Reference: <https://thebiogrid.org/230579/summary/mus-musculus/actr1b.html> ([@B36]).

MATERIALS AND METHODS
=====================

*A. nidulans* strains and media
-------------------------------

*A. nidulans* strains used in this study are listed in [Table 5](#T5){ref-type="table"}. UV mutagenesis on spores of *A. nidulans* strains was done as previously described ([@B85]; [@B93]). Solid rich medium was made of either YAG (0.5% yeast extract and 2% glucose with 2% agar) or YAG+UU (YAG plus 0.12% uridine and 0.12% uracial). Genetic crosses were done by standard methods. Solid minimal medium containing 1% glucose was used for selecting progeny from a cross. For live-cell imaging experiments, cells were cultured in liquid minimal medium containing 1% glycerol overnight at 32°C. All the biochemical analyses were done using cells grown overnight at 32°C in liquid YG-rich medium (0.5% yeast extract and 2% glucose).

###### 

*A. nidulans* strains used in this study.

  Strain    Genotype                                                                                                                          Source
  --------- --------------------------------------------------------------------------------------------------------------------------------- ------------
  XX222     GFP-*nudA*^HC^*; argB*2*::\[argB\*-alcAp*::mCherry*-RabA\];*∆*nkuA::argB; pantoB*100; *yA*2                                       ( [@B109])
  XY13      p150-GFP*-AfpyrG;*∆*nkuA::argB*; *pyrG*89; *pyroA*4                                                                               ( [@B99])
  XY42      *argB*2*::\[argB\*-alcAp*::mCherry*-RabA\];*∆*nkuA::argB; pantoB*100; *yA*2                                                       ( [@B67])
  *eedD*5   *eedD*5 (*prp40A*^L438\*^); *hhoA*-GFP-*AfriboB*; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pantoB*100; ∆*nkuA::argB*           This work
  JZ788     Arp11-GFP*-AfpyrG; argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pantoB*100; ∆*nkuA::argB; yA*2                                      This work
  JZ901     *prp40A*^L438\*^; Arp11-GFP*-AfpyrG; argB*2*::\[argB\*-alcAp::*mCherry*-rabA\]; ∆nkuA::argB; yA*2                                 This work
  RQ246     Prp40A(1-437)-GFP; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\];*∆*nkuA::argB; pantoB*100; *yA*2                                    This work
  RQ249     Prp40A-GFP; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\];*∆*nkuA::argB; pantoB*100; *yA*2                                           This work
  RQ255     ∆*prp40A-AfpyrG*; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pantoB*100; ∆*nkuA::argB; yA*2                                      This work
  XX357     *hhoA*-GFP-*AfriboB*; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pyrG*89; *pantoB*100; ∆*nkuA::argB*                             This work
  XX402     *hhoA*-GFP-*AfriboB*; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pantoB*100; ∆*nkuA::argB*                                       This work
  XX403     *hhoA*-GFP-*AfriboB*; *argB*2*::\[argB\*-alcAp*::mCherry*-rabA\]; pyrG*89; ∆*nkuA::argB*                                          This work
  XX470     *prp40A*^L438\*^; GFP-*nudA*^HC^*; argB*2*::\[argB\*-alcAp*::mCherry*-rabA\];* possibly ∆*nkuA::argB*                             This work
  XX471     *prp40A*^L438\*^; p150-GFP-*AfpyrG*                                                                                               This work
  XX498     ∆*prp40A-AfpyrG*; *hhoA*-GFP-*AfriboB*; possibly ∆*nkuA::argB;* possibly *yA*2                                                    This work
  XX512     ∆*prp40A-AfpyrG*; GFP-*nudA*^HC^*; argB*2*::\[argB\*-alcAp*::mCherry*-rabA\];*∆*nkuA::argB; pyrG*89; possibly *yA*2               This work
  XX513     ∆*prp40A-AfpyrG*; p150-GFP-*AfpyrG; argB*2*::\[argB\*-alcAp*::mCherry*-rabA\];*∆*nkuA::argB*; possibly *pyrG*89; possibly *yA*2   This work

Live-cell imaging and analyses
------------------------------

All images were captured using an Olympus IX73 inverted fluorescence microscope linked to a PCO/Cooke Corporation Sensicam QE cooled CCD camera. An UPlanSApo 100× objective lens (oil) with a 1.40 numerical aperture was used. A filter wheel system with GFP/mCherry-ET Sputtered series with high transmission (Biovision Technologies) was used. The IPLab software was used for image acquisition and analysis. For all images, cells were grown in the LabTek Chambered \#1.0 borosilicate coverglass system (Nalge Nunc International, Rochester, NY). For the analysis on the frequency and velocity of early-endosome transport, cells were grown for overnight at 32°C and time-lapse sequences were captured at room temperature. All the images were taken with a 0.1-s exposure time (binning: 2 × 2). The hyphal-tip region was defined as a region within ∼2 μm to the hyphal tip. For measuring early-endosome movement, we focused on movements within ∼7 μm to the hyphal tip within the hyphal-tip cell ("hyphal-tip cell" refers to the hyphal segment between the hyphal tip and the most proximal septum). Retrograde movements initiating from the hyphal tip region are defined as "dynein-mediated." Thirty frames were taken for each sequence with a 0.1-s exposure time and a 0.3-s interval between frames, and the "generate-kymograph" and "measure-kymograph functions" of IPLab were used for analysis. For measuring the signal intensity of the individual GFP-dynein or p150-GFP comets, we followed a previously described method ([@B109]). Specifically, an area containing the whole comet was selected as a region of interest (ROI), and the Max/Min tool of the IPLab program was used to measure the maximal intensity within the ROI. Then the ROI box was dragged outside of the cell to take the background value, which was then subtracted from the value of the comet.

Construction of the strain containing the Prp40A-GFP allele at the PrpA40 locus
-------------------------------------------------------------------------------

Constructions of all strains are done by using standard procedures used in *A. nidulans* ([@B96]; [@B56]; [@B78]). For constructing the Prp40A-GFP fusion, we used the following six oligos to amplify genomic DNA and the GFP-*AfpyrG* fusion ([@B96]): AN1249-51 (5′-CGGCGGTGTTAG­TTCACTC-3′), AN1249-34 (5′-CGCCTGCACCAGCTCCATCCTCCTCAATCTCTCCTTCC-3′), GA4F (5′-GGAGCTGGTGCAGGCG-3′), AN1249-35 (5′-TCCCATATTCACCGTACACCTCTACTGTCTGAGAGGAGGCACTGAT-3′), AN1249-53 (5′-TAGAGGTGTACGGTGAA­TATGGGA-3′), and AN1249-36 (5′-GAATTGTGAATGACCCGCCAC-3′). Specifically, AN1249-51 and AN1249-34 were used to amplify the 2.1-kb fragment in the coding region, and AN1249-53 and AN1249-36 were used to amplify the 1-kb fragment in the 3′ untranslated region using wild-type genomic DNA as template, and GA4F and AN1249-35 were used to amplify the 2.7-kb GFP-*AfpyrG* fragment using genomic DNA from the RQ69 strain ([@B67]) containing p25-GFP-*AfpyrG* as template. We then used two oligos, AN1249-52 (5′-TTACGTGGACCCCGTAATGAT-3′) and AN1249-36, for a fusion PCR of the three fragments to generate the 4.7-kb PRP40-GFP-AfpyrG fragment that we used to transform into XY42 containing ∆*nkuA* ([@B56]) and mCherry-RabA ([@B2]; [@B110]; [@B67]). The transformants were screened by microscopically observing the GFP signals in cell nuclei and further confirmed by Western blot with a polyclonal anti-GFP antibody from Clontech.

Construction of the strain containing the Prp40A(1-437)-GFP allele at the PrpA40 locus
--------------------------------------------------------------------------------------

For constructing the Prp40A(1-437)-GFP strain, we made the Prp40A(1-437)-GFP-*AfpyrG* fragment by inserting the GFP-*AfpyrG* fragment into the Prp40A^Leu438\*^ mutation site right before the stop codon. The following oligos were used to make the Prp40A(1-437)-GFP-*AfpyrG* construct: AN1249-51, GA4F, AN1249-52, AN1249-36, AN1249-31 (5′-CGCCTGCACCAGCTCCCGACCTTTCTTCTTCTTCGAC-3′), AN1249-32 (5′-ATCATTACGGGGTCCACGTAACTGTCTGAGAGGAGGCACTG -3′), and AN1249-33 (5′-CAGGAACAGCAGATGTAGGC-3′). Specifically, AN1249-51 and AN1249-31 were used to amplify a 1-kb fragment of the 5′ coding region, and AN1249-52 and AN1249-36 were used to amplify a 2.1-kb fragment containing the 3′ coding region and 3′ untranslated region using wild-type genomic DNA as template, and GA4F and AN1249-32 were used to amplify the 2.7-kb GFP-*AfpyrG* fragment using genomic DNA from the RQ69 ([@B67]) strain as template. We then used two oligos, AN1249-51 and AN1249-33, for a fusion PCR to fuse the three fragments to generate the 4.7-kb Prp40A(1-437)-GFP-*AfpyrG* fragment that we used to transform the XY42 strain. The transformants were screened by microscopically observing the GFP signals in nuclei and further confirmed by Western blotting analysis with a polyclonal anti-GFP antibody from Clontech.

Construction of the ∆ *prp40A* mutant
-------------------------------------

For constructing the ∆*prp40A* mutant, we used fusion PCR to make the ∆prp40A (An1249) construct with the selective marker *pyrG* from *Aspergillus fumigatus*, *AfpyrG*, in the middle of the sequences flanking the Prp40A open reading frame. Specifically, AN1249-55 (5′-TCACGAGTCGGTGTTGGATTC-3′) and AN1249-39 (5′-TTTGCACCTTGATGACAAGTTTTCAA-3′) were used to amplify a ∼0.7-kb 5′ untranslated region from the strain containing PrpA40-GFP, and AN1249-58 (5′-TTGAAAACTTGTCATCAAGGTGCAAAACCGGTCGCCTCAAACAAT-3′) and AN1249-38 (5′-CAAATCACAGGCTGAAGACACG-3′) were used to amplify a 2.5-kb fragment containing *AfpyrG* and 3′ untranslated region from the Prp40A-GFP strain, and the two fragments were fused together by fusion PCR using AN1249-54 (5′-GATTCTGGAGGTGGGCTTTTAG-3′) and AN1249-37 (5′-CGTATTGAAGAAACTGCCAGGT-3′) as primers. The product (∼3.0 kb) was transformed into the XY42 strain. The transformants were first screened by the obvious small-colony phenotype. Site-specific integration in the ∆*prp40A* mutant was verified by PCR amplification using one oligo pair of AN1249-55 and AFPyrG3 (5′-GTTGCCAGGTGAGGGTATTT-3′), which should generate a ∼700 bp product from the ∆*prp40A* mutant but no product from a wild-type control, and another pair of AN1249-37 and AN1249-52 (5′-TTACGTGGACCCCGTAATGAT-3′), which should generate no product from the ∆*prp40A* mutant but a 1.7-kb product from the wild type control.

Construction of the ∆ *prp5A* and ∆ *clf1A* mutants
---------------------------------------------------

For constructing the ∆*prp5A* mutant, we first made the ∆prp5A (An1266, [www.AspGD.org](http://www.AspGD.org)) construct with the selective marker *AfpyrG*, in the middle of the linear construct. Specifically, we used APYRGF (5′-TGCTCTTCACCCTCTTCGCG-3′), and APYRGR (5′-CTGTCTGAGAGGAGGCACTGA-3′) as primers and the pFNO3 plasmid (deposited in the FGSC by Stephen Osmani) as a template to amplify a 1.9-kb AfpyrG fragment. We used PRP5NN (5′-ACTTA­TCCTTCATAGCATTGACCC-3′), PRP5NC (5′-CGCGAAGAGGGA­GAAGAGCATGTTGCAGGCCAGCAATGAG-3′), PRP5CN (5′-ATCAGTGCCTCCTCTCAGACAGAAATGCGCGCCTGTAACATAC-3′), and PRP5CC (5′-CGCCAAGTCCTATCTCTTATCG-3′) as primers and wild-type genomic DNA as a template to amplify 1-kb fragments upstream and downstream of *prp5A*'s coding sequence. We then used PRP5NN1 (5′-GGCAAGGTAGGCAGTAACTTC-3′) and PRP5CC1 (5′-ACGACGAAGCATAGGCAGA-3′) to perform a fusion PCR to fuse the three fragments and obtained a 3.9-kb fragment, which we transformed into the *A. nidulans* strain XY42 ([@B67]).

For constructing the ∆*clf1A* mutant, we first made the ∆clf1A (An1259, [www.AspGD.org](http://www.AspGD.org)) construct with the selective marker *AfpyrG*. We used CLF1NN (5′-TGCAGACACAATGCGAATTGC-3′), CLF1NC (5′-CGCGAAGAGGGAGAAGAGCAATCTGAGAGAGCT­GGTGCAATAG-3′), CLF1CN (5′-ATCAGTGCCTCCTCTCAGACAGTACATACAAGCGCCCGCTG-3′), and CLF1CC (5′-GTGAGAGGG­TGATTAATTAATTTGGAC-3′) as primers and wild-type genomic DNA as a template to amplify 1-kb fragments upstream and downstream of *clf1A*'s coding sequence. We then used two primers, CLF1NN1 (5′-TGTCTCTTCAGGTCATTGGG-3′) and CLF1CC1 (5′-GGATAGGCTGGCACTGAAAC-3′), to perform a fusion PCR to fuse these fragments with AfpyrG and obtained a 3.9-kb fragment, which we transformed into the XY42 strain.

The transformants obtained were streaked out on both YAG and YUU plates as a standard procedure for analyzing essential genes ([@B61]). Many colonies were nonviable on YAG but viable on YUU, consistent with the lethality of the ∆*prp5A* and ∆*clf1A* mutants ([@B61]).

Construction of the Arp11-GFP strain
------------------------------------

For constructing the Arp11-GFP fusion, we used the following six oligos to amplify genomic DNA and the GFP-AfpyrG fusion from the plasmid pFNO3: A11GNC (5′-GGCTCCAGCGCCTGCACCAGC­TCCCCCCCACCCTGCCAACGTCC-3′), A11GNN (5′-TGTTTACGCGGCTTTTGGGC-3′), A11GCN (5′-ATCAGTGCCTCCTCTCAGACAGTTAGCCGGGAGGCTTTTCTC-3′), A11GCC (5′-TTCCCTGG­CGACGTCCTCAC-3′), GAGAF (5′-GGAGCTGGTGCAGGCGCTG-3′), and pyrG3 (5′-CTGTCTGAGAGGAGGCACTGAT-3′). A fusion PCR was performed using A11GNN and A11GCC as primers to generate the 4.7 kb Arp11-GFP-AfpyrG fragment that we used to transform into XY42. Transformants were screened for GFP signals under microscope and positive strains were confirmed by PCR using these two oligos: AfpyrG5 (5′-AGCAAAGTGGACTGATAGC-3′) and A11GCC2 (5′-CATGCGCTACAGGGCTTCC-3′), which should generate a 1.1-kb product.

Biochemical pull-down assays, Western analysis, and mass spectrometry analysis
------------------------------------------------------------------------------

The μMACS GFP-tagged protein isolation kit (Miltenyi Biotec) was used to pull down GFP-tagged proteins and proteins associated with them. About 0.4 g hyphal mass was harvested from overnight culture for each sample, and cell extracts were prepared using a lysis buffer containing 50 mM Tris-HCl, pH 8.0, and 10 μg/ml protease inhibitor cocktail (Sigma-Aldrich). Cell extracts were centrifuged at 8000 × *g* for 15 min and then 16,000 × *g* for 15 min at 4°C, and supernatant was used for the pull-down experiment. To pull down GFP-tagged proteins, 25 μl anti-GFP MicroBeads were added into the cell extracts for each sample and incubated at 4°C for 30 min. The MicroBeads/cell extracts mixture was then applied to the μColumn followed by gentle wash with the lysis buffer used above for protein extraction (Miltenyi Biotec). Preheated (95°C) SDS--PAGE sample buffer was used as elution buffer. Western analyses were performed using the alkaline phosphatase system and blots were developed using the AP color development reagents from Bio-Rad. The antibody against GFP was from Clontech (polyclonal). A polyclonal antibody against Arp1 was generated in a previous study by injecting proteins produced in bacteria into rabbits followed by affinity purification of the antibody ([@B108]). Quantitation of the protein band intensity was done using the IPLab software as described previously ([@B66]). Specifically, an area containing the whole band was selected as a ROI, and the intensity sum within the ROI was measured. Then, the ROI box was dragged to the equivalent region of the negative control lane or a blank region without any band on the same blot to take the background value, which was then subtracted from the intensity sum. For proteomic analysis, eluted protein samples were run on an SDS--PAGE gel until proteins had reached the interphase between the stacking and the separating gels as previously described ([@B49]). A single gel slice containing the proteins was sliced out for mass spectrometry analysis of each sample, which was done using the Taplin Mass Spectrometry Facility at Harvard Medical School.
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